Gene · 7939
NIH grants1,570
NIH grants whose papers are about the gene, through NIH's grant-paper links.
641 to 660 of 1,570
Download this page as JSON| Grant | Title | LAP papers | Newest fiscal year |
|---|---|---|---|
| U54CA209978 | Combating Subclonal Evolution of Resistant Cancer Phenotypes | 1 | 2021 |
| U54CA209988 | Measuring, Modeling and Controlling Heterogeneity | 1 | 2021 |
| U54CA209997 | Structural and Functional Biology-based analysis of non-oncogene cancer dependencies | 1 | 2021 |
| U54CA217377 | Quantitative and functional characterization of therapeutic resistance in cancer | 1 | 2021 |
| UH3TR003090 | Joint Pain on a Chip: Mechanistic Analysis Therapeutic Targets and an Empirical Strategy for Personalized Pain Management | 1 | 2021 |
| UM1HG009375 | Comprehensive linking of DNA Elements in high-priority ENCODE Biosamples to their promoter targets | 1 | 2021 |
| ZIAES103286 | Characterization of the molecular mechanisms of LC3-associated phagocytosis and its role in disease pathogenesis | 1 | 2021 |
| R01HL133191 | Oral Tolerance for Hemophilia | 4 | 2020 |
| R01CA154649 | The role of entosis in human cancers | 3 | 2020 |
| K23GM120630 | Epigenetic mediated long-term aberrations in myeloid cells after critical illness | 2 | 2020 |
| P30NS048154 | Rocky Mountain Neurological Disorders Core Center | 2 | 2020 |
| R00HL127295 | Molecular and Cellular Mechanisms of Neonatal Cardiac Development and Repair | 2 | 2020 |
| R01AI123286 | Tuberculosis and T cell Recognition | 2 | 2020 |
| R01AR044016 | Inter-junctional signaling in epithelial junctional complex | 2 | 2020 |
| R01DE026170 | Microengineering the Dental Pulp Vascular Microenvironment | 2 | 2020 |
| R01DK091190 | Adenosine in Renal Sympathetic Neurotransmission | 2 | 2020 |
| R01GM098389 | Coupling kinetochore microtubule dynamics to chromosome motion | 2 | 2020 |
| R01GM116991 | Fluorescent mRNA Labeling Using Self-Alkylating Ribozymes | 2 | 2020 |
| R01GM117475 | Novel Regulatory Factors of the Spindle Assembly Checkpoint | 2 | 2020 |
| R01HL132353 | Hydrogels to Study Synergistic Effects of Signaling Factors and Matrix Mechanics on Valve Disease Progression | 2 | 2020 |
Source NIH's project filesgene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7939/grants?page=33